Insmed to host commercial webinar on June 4 to discuss market outlook for ARIKAYCE, brensocatib, treprostinil palmitil

INSMED Inc

Webinar at 8:00 a.m. ET on June 4, 2024, live via investor relations website.
Focus on three programs: ARIKAYCE (amikacin liposome inhalation), brensocatib, and treprostinil palmitil inhalation powder.
Slide presentation furnished as Exhibit 99.1 with title slide only; no specific financial data disclosed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.